SCHEMBL18488676

SCHEMBL18488676

CCc1ncc(Cl)c(NCCc2ccccc2Cl)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
HDAC3 O15379 2/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
SLC26A6 Q9BXS9 1/20 0.43
HIF1A Q16665 1/20 0.41
CCND3 P30281 1/20 0.41
CDK6 Q00534 1/20 0.41
SRC P12931 2/20 0.39
ABL1 P00519 1/20 0.39
GPR84 Q9NQS5 1/20 0.39
JAK2 O60674 1/20 0.39
TNK2 Q07912 1/20 0.39
ALK Q9UM73 1/20 0.39
STK17A Q9UEE5 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18488361 0.85 CYP2D6 (0.49) TAAR1NPC1RAB9ASTK17ASTK17B
SCHEMBL18488334 0.84 GPR84 (0.42) TAAR1KMT2AGPR84STK17ASTK17B
SCHEMBL18488672 0.83 MEN1 (0.50) TAAR1MEN1NPC1RAB9AKMT2A
SCHEMBL18488975 0.82 PGK1 (0.48) TAAR1NPC1RAB9AHIF1ALMNA
SCHEMBL31044942 0.76 NPC1 (0.45) TAAR1MEN1NPC1RAB9AKMT2A
SCHEMBL18487897 0.74 CCND3 (0.41) TAAR1MEN1NPC1RAB9AKMT2A
SCHEMBL18493897 0.74 STK17B (0.43) TAAR1MEN1NPC1RAB9AKMT2A
SCHEMBL6267961 0.71 HDAC3 (0.48) TAAR1MEN1NPC1RAB9AKMT2A
SCHEMBL20421838 0.71 CCND3 (0.53) TAAR1HIF1ACCND3CDK6SRC
SCHEMBL30395436 0.71 CCND3 (0.53) TAAR1HIF1ACCND3CDK6SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017023899-A1 INHIBITORS OF ACK1/TNK2 TYROSINE KINASE H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE (US) 2017-02-09 WO disclosed